Shattuck Labs



Shattuck is a clinical-stage biotechnology company advancing its proprietary Agonist Redirected Checkpoint (ARC™) platform to develop a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and inflammatory diseases.

Andrew R. Neill
Casi Deyoung
Chief Business Officer
Lini Pandite
Chief Medical Officer
Erin Ator Thomson
General Counsel
Fatima Rangwala
VP, Clinical Development
George Fromm
VP, Research & Development
James Stout
VP, Chemistry, Manufacturing & Controls
Suresh De Silva
VP, Product Development
Thomas Lampkin
VP, Regulatory Affairs
Bo Ma
VP, Biometrics
Kelli Collin
VP, Quality

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.